Optimization and Therapeutic Activity of Liposome-Conjugated Monoclonal Antibodies Against the ErbB family of Receptor Tyrosine Kinases: First Step in the Development of Therapeutic Antibody/Liposomal Anticancer Drug Combinations

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 10, 2006-12 ,pp. : 704-713

Bentham Science Publishers

Access to resources Recommend Favorite

A Comparative QSAR Analysis of Quinazoline Analogues as Tyrosine Kinase (erbB-2) Inhibitors

By  

Medicinal Chemistry, Vol. 7, Iss. 3, 2011-05 ,pp. : 200-212

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of monoclonal antibodies (mAb) against native and recombinant human mannose-binding lectin (MBL)

By Zhao H.   Stahl G.L.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite

Pharmacological characterization of homobaclofen on wild type and mutant GABA B 1b receptors coexpressed with the GABA B 2 receptor

By Jensen A.A.   Madsen B.E.   Krogsgaard-Larsen P.   Brauner-Osborne H.  

European Journal of Pharmacology, Vol. 417, Iss. 3, 2001-04 ,pp. : 177-180

Elsevier

Access to resources Recommend Favorite

EGF-receptor targeting with monoclonal antibodies in colorectal carcinomas: rationale for a pharmacogenomic approach

By Loupakis Fotios   Vasile Enrico   Santini Daniele   Masi Gianluca   Falcone Alfredo   Graziano Francesco  

Pharmacogenomics, Vol. 9, Iss. 1, 2008-01 ,pp. : 55-69

Future Medicine

Access to resources Recommend Favorite